Suppr超能文献

原发性甲状旁腺功能亢进的非典型表现。

Nontraditional manifestations of primary hyperparathyroidism.

机构信息

Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

出版信息

J Clin Densitom. 2013 Jan-Mar;16(1):40-7. doi: 10.1016/j.jocd.2012.11.008.

Abstract

Classical primary hyperparathyroidism (PHPT) was previously a multisystemic symptomatic disorder not only with overt skeletal and renal complications but also with neuropsychological, cardiovascular, gastrointestinal, and rheumatic effects. The presentation of PHPT has evolved, and today most patients are asymptomatic. Osteitis fibrosa cystica is rarely seen today, and nephrolithiasis is less common. Gastrointestinal and rheumatic symptoms are not part of the clinical spectrum of modern PHPT. It remains unclear whether neuropsychological symptoms and cardiovascular disease, neither of which are currently indications for recommending parathyroidectomy (PTX), are part of the modern phenotype of PHPT. A number of observational studies suggest that mild PHPT is associated with depression, decreased quality of life, and changes in cognition, but limited data from randomized controlled trials (RCTs) have not indicated consistent benefits after surgery. The increased cardiovascular morbidity and mortality in severe PHPT has not been definitively demonstrated in mild disease, although there is some evidence for more subtle cardiovascular abnormalities, such as increased vascular stiffness, among others. Results from observational studies that have assessed the effect of PTX on cardiovascular health have been conflicting. The single RCT in this area did not demonstrate that PTX was beneficial. Despite recent progress in these areas, more data from rigorously designed studies are needed to better inform the clinical management of patients with asymptomatic PHPT.

摘要

经典原发性甲状旁腺功能亢进症(PHPT)以前是一种多系统症状性疾病,不仅有明显的骨骼和肾脏并发症,还有神经心理、心血管、胃肠道和风湿效应。PHPT 的表现已经发生了演变,今天大多数患者无症状。如今,纤维囊性骨炎很少见,肾结石也较少见。胃肠道和风湿症状不是现代 PHPT 临床谱的一部分。目前尚不清楚神经心理症状和心血管疾病是否属于现代 PHPT 表型,这两者都不是推荐甲状旁腺切除术(PTX)的指征。一些观察性研究表明,轻度 PHPT 与抑郁、生活质量下降和认知改变有关,但来自随机对照试验(RCT)的有限数据表明手术后并没有一致的益处。在轻度疾病中,尚未明确证实严重 PHPT 中增加的心血管发病率和死亡率,但有一些证据表明存在更微妙的心血管异常,如血管僵硬增加等。评估 PTX 对心血管健康影响的观察性研究结果存在矛盾。该领域的唯一 RCT 并未表明 PTX 有益。尽管在这些领域取得了最近的进展,但仍需要更多来自精心设计研究的数据,以更好地为无症状 PHPT 患者的临床管理提供信息。

相似文献

1
Nontraditional manifestations of primary hyperparathyroidism.
J Clin Densitom. 2013 Jan-Mar;16(1):40-7. doi: 10.1016/j.jocd.2012.11.008.
2
Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: A narrative review.
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):981-996. doi: 10.1016/j.numecd.2020.12.029. Epub 2021 Jan 5.
3
Asymptomatic primary hyperparathyroidism.
J Clin Densitom. 2013 Jan-Mar;16(1):14-21. doi: 10.1016/j.jocd.2012.11.005.
4
Non classical complications of primary hyperparathyroidism.
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):805-820. doi: 10.1016/j.beem.2018.06.006. Epub 2018 Jun 18.
5
Nontraditional Aspects of Sporadic Primary Hyperparathyroidism.
Endocrinol Metab Clin North Am. 2021 Dec;50(4):629-647. doi: 10.1016/j.ecl.2021.07.007.
6
Classical and Nonclassical Manifestations of Primary Hyperparathyroidism.
J Bone Miner Res. 2022 Nov;37(11):2330-2350. doi: 10.1002/jbmr.4679. Epub 2022 Oct 17.
7
Meta-analysis on the Effect of Mild Primary Hyperparathyroidism and Parathyroidectomy Upon Arterial Stiffness.
J Clin Endocrinol Metab. 2021 May 13;106(6):1832-1843. doi: 10.1210/clinem/dgab157.
8
Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism.
Eur J Endocrinol. 2012 Aug;167(2):277-85. doi: 10.1530/EJE-12-0124. Epub 2012 Jun 1.
9
An overview of normocalcemic primary hyperparathyroidism.
Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):413-21. doi: 10.1097/MED.0000000000000198.
10
Cardiovascular aspects of primary hyperparathyroidism.
J Endocrinol Invest. 2008 Oct;31(10):925-31. doi: 10.1007/BF03346443.

引用本文的文献

1
An Analysis of Primary Hyperparathyroidism in Association with Depression or Anxiety.
Diseases. 2025 Feb 12;13(2):54. doi: 10.3390/diseases13020054.
2
The Russian registry of primary hyperparathyroidism, latest update.
Front Endocrinol (Lausanne). 2023 Jul 3;14:1203437. doi: 10.3389/fendo.2023.1203437. eCollection 2023.
4
Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?
Biomed Res Int. 2019 Jul 1;2019:2150159. doi: 10.1155/2019/2150159. eCollection 2019.
6
The characteristics of clinical changes in primary hyperparathyroidism in Chinese patients.
J Bone Miner Metab. 2019 Mar;37(2):336-341. doi: 10.1007/s00774-018-0922-3. Epub 2018 May 2.
7
Emerging evidence on the link between depressive symptoms and bone loss in postmenopausal women.
Int J Womens Health. 2017 Dec 28;10:1-9. doi: 10.2147/IJWH.S147006. eCollection 2018.
8
Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism.
Vasc Health Risk Manag. 2017 Jun 22;13:225-229. doi: 10.2147/VHRM.S128084. eCollection 2017.
9
Primary Hyperparathyroidism.
F1000Res. 2016 Jan 4;5. doi: 10.12688/f1000research.7039.1. eCollection 2016.

本文引用的文献

2
Primary hyperparathyroidism and celiac disease: a population-based cohort study.
J Clin Endocrinol Metab. 2012 Mar;97(3):897-904. doi: 10.1210/jc.2011-2639. Epub 2012 Jan 11.
4
Aortic valve calcification in mild primary hyperparathyroidism.
J Clin Endocrinol Metab. 2012 Jan;97(1):132-7. doi: 10.1210/jc.2011-2107. Epub 2011 Oct 26.
5
Depression in primary hyperparathyroidism: prevalence and benefit of surgery.
J Clin Endocrinol Metab. 2011 Nov;96(11):E1737-45. doi: 10.1210/jc.2011-1486. Epub 2011 Sep 14.
7
The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism.
Echocardiography. 2011 Oct;28(9):955-60. doi: 10.1111/j.1540-8175.2011.01468.x. Epub 2011 Aug 9.
8
Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.
J Endocrinol Invest. 2012 Jun;35(6):548-52. doi: 10.3275/7861. Epub 2011 Jul 12.
9
Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism.
Atherosclerosis. 2011 Sep;218(1):96-101. doi: 10.1016/j.atherosclerosis.2011.05.010. Epub 2011 May 18.
10
Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
J Clin Endocrinol Metab. 2011 Jul;96(7):2112-8. doi: 10.1210/jc.2011-0238. Epub 2011 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验